FDA Inspection 1120420 — Georgetown University IRB

Georgetown University IRB — FEI 1121206

The FDA completed an inspection of Georgetown University IRB on March 11, 2020 in Washington, DC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 11, 2020
Fiscal Year
2020
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Washington, DC (United States)

Additional Details

IRB

Citations

IDCFRDescription
731821 CFR 56.115(a)(2)Minutes of IRB meetings